Colorectal cancer: managing secondary bowel obstruction

  • Harvey PR & al.
  • Int J Colorectal Dis
  • 7 Jun 2019

  • curated by Dawn O'Shea
  • Medical news
Access to the full content of this site is available only to registered healthcare professionals. Access to the full content of this site is available only to registered healthcare professionals.

In patients with bowel obstruction secondary to colorectal cancer (CRC), metal stents (MS) as a bridge to resection are associated with improved outcomes.

A study, published in the International Journal of Colorectal Diseases, used Hospital Episode Statistics (HES) to study a large cohort of subjects undergoing MS insertion followed by semi-elective curative resection in comparison with subjects undergoing immediate resection for bowel obstruction due to CRC.

Over a 10-year period, 4571 subjects were identified; 401 received MS and 4170 underwent surgery only. Median age was 71 years among MS subjects and 73 years in surgery-only subjects. Following propensity matching, 375 MS and 375 surgery-only subjects remained.

MS was associated with a lower rate of 30-day readmissions (7.5% vs 11.7%; P=0.047) and fewer respiratory complications (

Mortality was lower in the MS group at 30 days (1.9% vs 8.8%; P

The authors say the findings support “the hypothesis that bridging colorectal MS for subjects presenting with bowel obstruction are of benefit to patients, by potentially avoiding high-risk emergency surgery.”

They say prospective randomised studies should focus on the opportunities provided by MS to optimise subjects prior to eventual curative resection.

Please confirm your acceptance

To gain full access to GPnotebook please confirm:

By submitting here you confirm that you have accepted Terms of Use and Privacy Policy of GPnotebook.

Submit